Physician profile
Cedric James Franklin Rutland
NPI 1811122799
$3,249,103.95
in general payments reported to CMS, 2019-2025
67 companies · $731K in 2025
The $731K reported for 2025 was more than what 99% of Critical Care Medicine (Internal Medicine) providers received nationally (typical 2025 total: $189).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $226K · 2020: $80K · 2021: $258K · 2022: $436K · 2023: $707K · 2024: $811K · 2025: $731K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1.3M · Consulting Fee: $662K · Travel and Lodging: $198K · Grant: $70K · Food and Beverage: $34K · Honoraria: $6,000 · Education: $252 · Gift: $17.21.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,279,698.98 |
| Consulting Fee | $661,992.54 |
| Travel and Lodging | $197,618.76 |
| Grant | $70,000.00 |
| Food and Beverage | $33,594.52 |
| Honoraria | $6,000.00 |
| Education | $251.54 |
| Gift | $17.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $1,010,591.53 | 2019-2025 | Nucala, Arexvy, Trelegy Ellipta |
| Genzyme Corporation | $793,996.06 | 2019-2025 | |
| Astrazeneca Pharmaceuticals Lp | $514,993.07 | 2019-2025 | Airsupra, Breztri, Tezspire |
| Regeneron Healthcare Solutions, INC. | $479,780.93 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $176,935.45 | 2019-2025 | Ofev, Spiriva, Jascayd |
| Pfizer INC. | $65,577.03 | 2020-2025 | |
| Modernatx, INC. | $54,245.22 | 2021-2024 | Moderna Covid-19 Vaccine |
| Genentech USA, INC. | $36,994.33 | 2019-2023 | Xolair |
| Sanofi-Aventis U.S. LLC | $27,585.00 | 2019-2023 | |
| Medtronic, INC. | $26,612.75 | 2025 | Mcgrath Mac, Nellcor |
| Olympus America INC. | $11,292.04 | 2021-2023 | Always-On Tip Tracked Forceps, 1.8mm Od, Serrated Cup, Spin Perc Localization Needle 19ga X 105mm, 1cm Marking Zone |
| United Therapeutics Corporation | $8,135.58 | 2021-2025 | Tyvaso |
| Amgen INC. | $7,675.90 | 2021-2025 | Tezspire, Evenity, Prolia |
| Regeneron Pharmaceuticals, INC. | $6,653.50 | 2022-2025 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $6,354.85 | 2022-2025 | Hyqvia, Cuvitru, Gammagard |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Verona Pharma, INC. | $6,344.11 | 2025 | Ohtuvayre |
| Veran Medical Technologies, INC. | $4,780.38 | 2019-2021 | |
| Chiesi USA, INC. | $2,200.00 | 2024 | |
| Sanofi Pasteur INC. | $1,233.00 | 2020 | |
| Genentech, INC. | $847.80 | 2019-2023 | Esbriet |
| Abbvie INC. | $732.18 | 2021-2025 | |
| Octapharma USA, INC. | $559.53 | 2022-2025 | Panzyga, Octagam Immune Globulin (Human), Cutaquig |
| Novartis Pharmaceuticals Corporation | $461.76 | 2019-2023 | |
| Grifols USA, LLC | $461.70 | 2019-2023 | Prolastin-C Liquid |
| Noah Medical Corporation | $434.31 | 2023-2024 | Galaxy |
| Shionogi INC | $264.88 | 2022-2024 | Fetroja |
| Janssen Pharmaceuticals, INC | $238.99 | 2019-2023 | Xarelto |
| Baxter Healthcare | $229.77 | 2022-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Volara System |
| Lilly USA, LLC | $198.79 | 2020-2025 | Mounjaro, Trulicity, Zepbound |
| Teva Pharmaceuticals USA, INC. | $175.11 | 2019-2022 | |
| Aero US INC | $167.35 | 2025 | Aerogen Solo Nebulizer System, Aerogen Solo; Aerogen Ultra, Aerogen Usb Controller System |
| Mylan Specialty L.P. | $159.73 | 2019-2021 | |
| Allergan, INC. | $151.21 | 2019-2020 | |
| Abiomed | $149.86 | 2022 | |
| Inari Medical, INC. | $149.07 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| La Jolla Pharmaceutical Company | $144.10 | 2020 | |
| Advanced Respiratory, INC | $135.30 | 2019-2021 | |
| Philips North America LLC | $129.88 | 2019-2023 | |
| Intuitive Surgical, INC. | $122.81 | 2023 | Da Vinci Surgical System |
| Pulmonx Corporation | $122.20 | 2021 | |
| Harmony Biosciences LLC | $116.23 | 2023-2024 | Wakix |
| Merck Sharp & Dohme LLC | $106.32 | 2019-2025 | Winrevair, Capvaxive |
| Biohaven Pharmaceutical Holding Company Ltd. | $102.43 | 2022 | |
| Insmed, INC. | $70.91 | 2024-2025 | Arikayce, Brinsupri |
| Ethicon INC. | $69.34 | 2021 | |
| Ani Pharmaceuticals, INC. | $67.06 | 2025 | Purified Cortrophin Gel |
| Circassia INC. | $56.49 | 2019-2024 | Niox |
| Nabriva Therapeutics, Plc | $51.97 | 2022 | |
| Cook Medical LLC | $50.86 | 2020 | |
| Exact Sciences Corporation | $42.10 | 2023 | Cologuard Collection Kit |
| Radius Health, INC. | $41.27 | 2020-2024 | Tymlos |
| Novo Nordisk INC | $38.20 | 2021 | |
| Liquidia Technologies, INC. | $32.71 | 2025 | Yutrepia |
| Melinta Therapeutics, LLC | $28.91 | 2019-2021 | |
| Pinnacle Biologics, INC | $24.74 | 2024 | Photofrin |
| Elucent Medical | $22.16 | 2022 | |
| Invivyd INC | $21.93 | 2025 | Pemgarda |
| Vifor Pharma, INC. | $20.54 | 2024 | Zemaira |
| Xeris Pharmaceuticals, INC. | $20.35 | 2021 | |
| Esperion Therapeutics, INC. | $18.69 | 2023 | Nexletol |
| Tactile Systems Technology INC | $16.65 | 2022 | |
| Tolmar, INC. | $16.54 | 2025 | Jatenzo |
| Jazz Pharmaceuticals INC. | $14.57 | 2019 | |
| Amarin Pharma, INC. | $12.50 | 2020 | |
| Alk-Abello, INC | $11.90 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.52 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,679.71 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cedric Franklin Rutland listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.